Because of a growing interest to treat type-II diabetes with gastric bypass surgery, the rapid and long-term improvement of insulin sensitivity and the reduction of diabetes in subjects post surgery has become a primary axis of interest. This evidence concerns the gene INS and type 2 diabetes mellitus.